# 2026-20552: Texas Pharmacy Busted for Sketchy Pill Prescriptions

2026-20552, Wellwise Pharmacy Inc.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-10-07, effective 2025-09-25; PRIA reads it as touching household money (as of 2026-10-14).

- Canonical: https://policyrisk.com/federal-register/2026-20552
- As of: 2026-10-14
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-20552
- Title: Wellwise Pharmacy Inc.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 64162
- Published: 2026-10-07
- Effective: 2025-09-25
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-14

## In one line

Texas Pharmacy Busted for Sketchy Pill Prescriptions

## Summary

Wellwise Pharmacy in Texas had its DEA registration suspended and is facing revocation because it kept filling risky prescriptions for controlled drugs without checking warning signs. This affects the pharmacy’s ability to legally handle these medicines, protecting public health and safety. The decision took effect immediately in late 2025, stopping Wellwise from operating under its DEA license and signaling serious legal and financial trouble ahead.

## Effects PRIA read

- Wellwise loses DEA controlled‑substance license: cost, high. The DEA suspended Wellwise Pharmacy's registration immediately on September 25, 2025 (DEA registration No. FW2318497) and the Agency later granted the Government's request to revoke that registration in the Decision published October 7, 2026. As a result, Wellwise is no longer authorized to legally…
- DEA action cites widespread unsafe dispensing: benefit, medium. The agency found that between January 2023 and March 2025 Wellwise repeatedly filled at least 1,360 prescriptions that showed multiple red flags of diversion or abuse (including pattern prescribing, prescriptions at highest strengths or large quantities, same‑address patients, long travel distances…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-23006](https://policyrisk.com/federal-register/2026-23006): Importer of Controlled Substances Application: NSI Lab Solutions LLC, 2026-11-12
- [2026-23075](https://policyrisk.com/federal-register/2026-23075): Schedules of Controlled Substances: Placement of Oveporexton in Schedule IV, 2026-11-12

## Sources
- [2026-20552 on federalregister.gov](https://www.federalregister.gov/documents/2026/10/07/2026-20552/wellwise-pharmacy-inc-decision-and-order)
- [2026-20552 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-10-07/pdf/2026-20552.pdf)

## Related
- [Previous: 2026-20551, Certain Paper Shopping Bags From Colombia: Preliminary Results of Antidumping D…](https://policyrisk.com/federal-register/2026-20551)
- [Next: 2026-20553, Decision and Order: Medpharm Research, LLC](https://policyrisk.com/federal-register/2026-20553)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-20552 (as of 2026-10-14).
